143 related articles for article (PubMed ID: 11114411)
1. Alpha interferon combined with ribavirin potentiates proliferative suppression but not cytokine production in mitogenically stimulated human lymphocytes.
Shiffman ML; Verbeke SB; Kimball PM
Antiviral Res; 2000 Nov; 48(2):91-9. PubMed ID: 11114411
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory activities of IFN-gamma1b in combination with type I IFN: implications for the use of IFN-gamma1b in the treatment of chronic HCV infections.
Wang T; Blatt LM; Seiwert SD
J Interferon Cytokine Res; 2006 Jul; 26(7):473-83. PubMed ID: 16800786
[TBL] [Abstract][Full Text] [Related]
3. Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results.
Bacon BR; Shiffman ML; Mendes F; Ghalib R; Hassanein T; Morelli G; Joshi S; Rothstein K; Kwo P; Gitlin N
Hepatology; 2009 Jun; 49(6):1838-46. PubMed ID: 19291790
[TBL] [Abstract][Full Text] [Related]
4. Ribavirin and IFN-alpha combination therapy induces CD4+ T-cell proliferation and Th1 cytokine secretion in patients with chronic hepatitis B.
Ren FY; Jin H; Piao XX; Piao FS
World J Gastroenterol; 2007 Nov; 13(41):5440-5. PubMed ID: 17907286
[TBL] [Abstract][Full Text] [Related]
5. Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients.
Martín J; Navas S; Quiroga JA; Pardo M; Carreño V
Cytokine; 1998 Aug; 10(8):635-44. PubMed ID: 9722937
[TBL] [Abstract][Full Text] [Related]
6. Ribavirin regulates hepatitis C virus replication through enhancing interferon-stimulated genes and interleukin 8.
Tokumoto Y; Hiasa Y; Uesugi K; Watanabe T; Mashiba T; Abe M; Kumagi T; Ikeda Y; Matsuura B; Onji M
J Infect Dis; 2012 Apr; 205(7):1121-30. PubMed ID: 22357660
[TBL] [Abstract][Full Text] [Related]
7. Effects of interferon and ribavirin combination therapy on CD4+ proliferation, lymphocyte activation, and Th1 and Th2 cytokine profiles in chronic hepatitis C.
Marinho RT; Pinto R; Santos ML; Lobos IV; Moura MC
J Viral Hepat; 2004 May; 11(3):206-16. PubMed ID: 15117322
[TBL] [Abstract][Full Text] [Related]
8. [Association between ribavirin plasma concentration and sustained virologic response in treatment of patients with genotype 1b chronic hepatitis C with pegylated interferon-α-2b and ribavirin].
Wang MR; Zhang X; Yang ZG; Li P; Gao L; Chen XH; Wang J; Xiong X; Wang SM; Geng JB; Hao KY; Xie F; Wang M; Zheng WK
Zhonghua Gan Zang Bing Za Zhi; 2016 Mar; 24(3):175-80. PubMed ID: 27095759
[TBL] [Abstract][Full Text] [Related]
9. Antiviral Effects of Clinically-Relevant Interferon-α and Ribavirin Regimens against Dengue Virus in the Hollow Fiber Infection Model (HFIM).
Pires de Mello CP; Drusano GL; Rodriquez JL; Kaushik A; Brown AN
Viruses; 2018 Jun; 10(6):. PubMed ID: 29890736
[TBL] [Abstract][Full Text] [Related]
10. Chikungunya Virus: In Vitro Response to Combination Therapy With Ribavirin and Interferon Alfa 2a.
Gallegos KM; Drusano GL; D Argenio DZ; Brown AN
J Infect Dis; 2016 Oct; 214(8):1192-7. PubMed ID: 27496974
[TBL] [Abstract][Full Text] [Related]
11. Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions.
Khakoo S; Glue P; Grellier L; Wells B; Bell A; Dash C; Murray-Lyon I; Lypnyj D; Flannery B; Walters K; Dusheiko GM
Br J Clin Pharmacol; 1998 Dec; 46(6):563-70. PubMed ID: 9862245
[TBL] [Abstract][Full Text] [Related]
12. [In vivo and vitro effects of interferon-alpha 2b on functional activity of T-lymphocytes from patients with rheumatoid arthritis].
Iarilina AA; Nikonova MF; Litvina MM; Balabanova RM; Iarilin AA
Ter Arkh; 2000; 72(5):9-17. PubMed ID: 11109610
[TBL] [Abstract][Full Text] [Related]
13. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients.
Laguno M; Murillas J; Blanco JL; Martínez E; Miquel R; Sánchez-Tapias JM; Bargallo X; García-Criado A; de Lazzari E; Larrousse M; León A; Loncá M; Milinkovic A; Gatell JM; Mallolas J
AIDS; 2004 Sep; 18(13):F27-36. PubMed ID: 15316335
[TBL] [Abstract][Full Text] [Related]
14. Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes.
Testoni B; Durantel D; Lebossé F; Fresquet J; Helle F; Negro F; Donato MF; Levrero M; Zoulim F
Gut; 2016 Apr; 65(4):672-82. PubMed ID: 26082258
[TBL] [Abstract][Full Text] [Related]
15. Treatment with ribavirin and interferon-alpha reduces interferon-gamma expression in patients with chronic hepatitis C.
Bergamini A; Bolacchi F; Cepparulo M; Demin F; Uccella I; Bongiovanni B; Ombres D; Angelico F; Liuti A; Hurtova M; Francioso S; Carvelli C; Cerasari G; Angelico M; Rocchi G
Clin Exp Immunol; 2001 Mar; 123(3):459-64. PubMed ID: 11298134
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
[TBL] [Abstract][Full Text] [Related]
17. The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C.
Zeuzem S; Buggisch P; Agarwal K; Marcellin P; Sereni D; Klinker H; Moreno C; Zarski JP; Horsmans Y; Mo H; Arterburn S; Knox S; Oldach D; McHutchison JG; Manns MP; Foster GR
Hepatology; 2012 Mar; 55(3):749-58. PubMed ID: 22006408
[TBL] [Abstract][Full Text] [Related]
18. An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin.
Ogawa E; Furusyo N; Kajiwara E; Takahashi K; Nomura H; Tanabe Y; Satoh T; Maruyama T; Nakamuta M; Kotoh K; Azuma K; Dohmen K; Shimoda S; Hayashi J;
J Infect Chemother; 2012 Oct; 18(5):689-97. PubMed ID: 22450877
[TBL] [Abstract][Full Text] [Related]
19. Immunological dynamics associated with rapid virological response during the early phase of type I interferon therapy in patients with chronic hepatitis C.
Lee JW; Kim W; Kwon EK; Kim Y; Shin HM; Kim DH; Min CK; Choi JY; Lee WW; Choi MS; Kim BG; Cho NH
PLoS One; 2017; 12(6):e0179094. PubMed ID: 28614389
[TBL] [Abstract][Full Text] [Related]
20. High dose consensus interferon in nonresponders to interferon alpha-2b and ribavirin with chronic hepatitis C.
Moskovitz DN; Manoharan P; Heathcote EJ
Can J Gastroenterol; 2003 Aug; 17(8):479-82. PubMed ID: 12945008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
